Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G2 checkpoint

Oncogene

Volumn 25, Issue 45, 2006, Pages 6037-6047

  Macip, S ^a   Kosoy, A ^a   Lee, S W ^b   O'Connell, M J ^a   Aaronson, S A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Checkpoints; Chk1; p53; ROS; Senescence

Indexed keywords

ANTINEOPLASTIC AGENT; CHECKPOINT KINASE 1; DOUBLE STRANDED DNA; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MEDIATOR RELEASE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENESCENCE;

ANIMALS; CELL LINE; FLOW CYTOMETRY; G2 PHASE; GENES, P53; HUMANS; NEOPLASMS; OXIDATIVE STRESS; PROTEIN KINASES;

EID: 33749830382     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209629     Document Type: Article

References (81)

1. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB et al. (1992). Proc Natl Acad Sci USA 89: 10114-10118.
2. Aubry JP, Blaecke A, Lecoanet-Henchoz S, Jeannin P, Herbault N, Caron G et al. (1999). Cytometry 37: 197-204.
3. Bai J, Cederbaum AI. (2003). J Biol Chem 278: 4660-4667.
4. Bakkenist CJ, Kastan MB. (2004). Cell 118: 9-17.
5. Bakondi E, Gonczi M, Szabo E, Bai P, Pacher P, Gergely P et al. (2003). J Invest Dermatol 121: 88-95.
6. Bartek J, Falck J, Lukas J. (2001). Nat Rev Mol Cell Biol 2: 877-886.
7. Bartek J, Lukas J. (2003). Cancer Cell 3: 421-429.
8. Bartkowiak D, Hogner S, Baust H, Nothdurft W, Rottinger EM. (1999). Cytometry 37: 191-196.
9. Barzilai A, Yamamoto K. (2004). DNA Repair (Amsterdam) 3: 1109-1115.
10. Caldini R, Chevanne M, Mocali A, Tombaccini D, Paoletti F. (1998). Mech Ageing Dev 105: 137-150.
11. Campisi J, Kim S, Lim CS, Rubio M. (2001). Exp Gerontol 36: 1619-1637.
12. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. (2004). Oncogene 23: 2825-2837.
13. Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y et al. (1999). Cancer Res 59: 3761-3767.
14. Chen Q, Ames BN. (1994). Proc Natl Acad Sci USA 91: 4130-4134.
15. Chen Q, Fischer A, Reagan JD, Yan LJ, Ames BN. (1995). Proc Natl Acad Sci USA 92: 4337-4341.
16. Chen QM, Bartholomew JC, Campisi J, Acosta M, Reagan JD, Ames BN. (1998). Biochem J 332: 43-50.
17. Chiu CC, Li CH, Ung MW, Fuh TS, Chen WL, Fang K. (2005). Cancer Lett 223: 249-258.
18. Clopton DA, Saltman P. (1995). Biochem Biophys Res Commun 210: 189-196.
19. Curman D, Cinel B, Williams DE, Rundle N, Block WD, Goodarzi AA et al. (2001). J Biol Chem 276: 17914-17919.
20. Davies KJ. (1999). IUBMB Life 48: 41-47.
21. de Magalhaes JP, Chainiaux F, de Longueville F, Mainfroid V, Migeot V, Marcq L et al. (2004). Exp Gerontol 39: 1379-1389.
22. de Vries HI, Uyetake L, Lemstra W, Brunsting JF, Su TT, Kampinga HH et al. (2005). J Cell Sci 118: 1833-1842.
23. Dean RT, Fu S, Stocker R, Davies MJ. (1997). Biochem J 324(Part 1): 1-18.
24. den Elzen N, Kosoy A, Christopoulos H, O'Connell MJ. (2004). Cell Cycle 3: 529-533.
25. den Elzen NR, O'Connell MJ. (2004). EMBO J 23: 908-918.
26. Di Leonardo A, Linke SP, Clarkin K, Wahl GM. (1994). Genes Dev 8: 2540-2551.
27. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). Proc Natl Acad Sci USA 92: 9363-9367.
28. Dumont P, Burton M, Chen QM, Gonos ES, Frippiat C, Mazarati J et al. (2000). Free Radic Biol Med 28: 361-373.
29. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 75: 817-825.
30. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA. (1999). Oncogene 18: 2789-2797.
31. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. (2004). DNA Repair (Amsterdam) 3: 959-967.
32. Finkel T, Holbrook NJ. (2000). Nature 408: 239-247.
33. Foster ER, Downs JA. (2005). FEBS J 272: 3231-3240.
34. Garber K. (2005). J Natl Cancer Inst 97: 1026-1028.
35. Gewirtz DA. (1999). Biochem Pharmacol 57: 727-741.
36. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. (1994). Cancer Res 54: 4855-4878.
37. Hammond EM, Dorie MJ, Giaccia AJ. (2003). J Biol Chem 278: 12207-12213.
38. Hampton MB, Orrenius S. (1998). Toxicol Lett 102-103: 355-358.
39. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. (1996). Mol Cell Biol 16: 859-867.
40. Hayflick L, Moorehead P. (1961). Exp Cell Res 25: 585-621.
41. Ho CC, Siu WY, Chow JP, Lau A, Arooz T, Tong HY et al. (2005). Exp Cell Res 304: 1-15.
42. Hwang ES. (2002). Mech Ageing Dev 123: 1681-1694.
43. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER et al. (1997). Science 275: 1649-1652.
44. Jackson JR, Gilmartin A, Imburgia C, Winkler JD, Marshall LA, Roshak A. (2000). Cancer Res 60: 566-572.
45. Jallepalli PV, Lengauer C, Vogelstein B, Bunz F. (2003). J Biol Chem 278: 20475-20479.
46. Kaneko YS, Watanabe N, Morisaki H, Akita H, Fujimoto A, Tominaga K et al. (1999). Oncogene 18: 3673-3681.
47. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. (1991). Cancer Res 51: 6304-6311.
48. Kaufmann WK, Levedakou EN, Grady HL, Paules RS, Stein GH. (1995). Cancer Res 55: 7-11.
49. Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O'Connell MJ. (2001). Oncogene 20: 7453-7463.
50. Latif C, Elzen NR, O'Connell MJ. (2004). J Cell Sci 117: 3489-3498.
51. Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T et al. (1999). J Biol Chem 274: 7936-7940.
52. Levine AJ. (1997). Cell 88: 323-331.
53. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K et al. (2000). Genes Dev 14: 1448-1459.
54. Long H, Han H, Yang B, Wang Z. (2003). Cell Physiol Biochem 13: 401-414.
55. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. (2003). Mol Cell Biol 23: 8576-8585.
56. Mason DX, Jackson TJ, Lin AW. (2004). Oncogene 23: 9238-9246.
57. Nelms BE, Maser RS, MacKay JF, Lagally MG, Petrini JH. (1998). Science 280: 590-592.
58. O'Connell MJ, Cimprich KA. (2005). J Cell Sci 118: 1-6.
59. Orr WC, Sohal RS. (1994). Science 263: 1128-1130.
60. Renschler MF. (2004). Eur J Cancer 40: 1934-1940.
61. Riley PA. (1994). Int J Radiat Biol 65: 27-33.
62. Roberson RS, Kussick SJ, Vallieres E, Chen SY, Wu DY. (2005). Cancer Res 65: 2795-2803.
63. Robles SJ, Adami GR. (1998). Oncogene 16: 1113-1123.
64. Roninson IB. (2003). Cancer Res 63: 2705-2715.
65. Roninson IB, Broude EV, Chang BD. (2001). Drug Resist Updat 4: 303-313.
66. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. (1997). Cell 88: 593-602.
67. Shackelford RE, Innes CL, Sieber SO, Heinloth AN, Leadon SA, Paules RS. (2001). J Biol Chem 276: 21951-21959.
68. Shiloh Y, Kastan MB. (2001). Adv Cancer Res 83: 209-254.
69. Smith JR, Pereira-Smith OM. (1996). Science 273: 63-67.
70. Sugrue MM, Shin DY, Lee SW, Aaronson SA. (1997). Proc Natl Acad Sci USA 94: 9648-9653.
71. Sun X, Majumder P, Shioya H, Wu F, Kumar S, Weichselbaum R et al. (2000). J Biol Chem 275: 17237-17240.
72. Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S et al. (2002). EMBO J 21: 5195-5205.
73. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. (2002). Cancer Res 62: 1876-1883.
74. Vogelstein B. (1990). Nature 348: 681-682.
75. von Zglinicki T, Saretzki G, Docke W, Lotze C. (1995). Exp Cell Res 220: 186-193.
76. Zamzami N, Marzo I, Susin SA, Brenner C, Larochette N, Marchetti P et al. (1998). Oncogene 16: 1055-1063.
77. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. (2000). Science 290: 989-992.
78. Zhao H, Watkins JL, Piwnica-Worms H. (2002). Proc Natl Acad Sci USA 99: 14795-14800.
79. Zhou BB, Bartek J. (2004). Nat Rev Cancer 4: 216-225.
80. Zhou BB, Elledge SJ. (2000). Nature 408: 433-439.
81. Zhu J, Woods D, McMahon M, Bishop JM. (1998). Genes Dev 12: 2997-3007.